Wellstat Management Co. LLC

Alexion Pharmaceuticals Inc. not only gained the FDA's approval on Oct. 23 for Strensiq (asfotase alfa) as a treatment for patients with perinatal-, infantile- and juvenile-onset hypophosphatasia (HPP

Last week was one of those weeks that makes you grateful that the stock markets close for the weekend. While the preparations and arrival of Pope Francis brought much of New York's Fifth Avenue and it

It's unclear now whether legislation introduced late last week that seeks to rein in drug prices will gain enough support to actually go anywhere on Capitol Hill. But with the Senate sponsor of the bi

The FDA's approval on Sept. 4 of Wellstat Therapeutics' hereditary orotic aciduria (HOA) treatment Xuriden (uridine triacetate) means AstraZeneca has gained a coveted rare pediatric disease priority r